Open Access
RESIDENT’S CORNER
Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma
Ramin Behzadigohar, Mark A. Rosenthal, Ben Tran
1
Department of Medical Oncology, The Royal Melbourne Hospital, Grattan St, Parkville, Victoria, Australia
Address correspondence to Dr. Ramin Behzadigohar,
Department of Medical Oncology, The Royal Melbourne
Hospital, Grattan St, Parkville VIC, Australia
Canadian Journal of Urology 2015, 22(3), 7824-7826.
Abstract
We report a case of an 82-year-old man with renal cell
carcinoma who developed a cardiac metastasis within the
interventricular septum. He had been under watchful
waiting for indolent metastatic renal cell carcinoma for
many years before developing symptoms consistent with
heart failure. At this time, a 44 mm interventricular septal
mass, consistent with a cardiac metastasis, was identified
as the cause of his symptoms. Pazopanib was initiated
which led to both a clinical and radiological response.
Keywords
cardiac metastases, renal cell carcinoma, pazopanib
Cite This Article
APA Style
Behzadigohar, R., Rosenthal, M.A., Tran, B. (2015). Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma. Canadian Journal of Urology, 22(3), 7824–7826.
Vancouver Style
Behzadigohar R, Rosenthal MA, Tran B. Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma. Can J Urology. 2015;22(3):7824–7826.
IEEE Style
R. Behzadigohar, M.A. Rosenthal, and B. Tran, “Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma,” Can. J. Urology, vol. 22, no. 3, pp. 7824–7826, 2015.
Copyright © 2015 The Canadian Journal of Urology.